Skip to main content
Caplight Logo









4BIO Capital

4BIO Capital

Overview

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector, investing in and supporting early-stage companies developing treatments in areas of high unmet medical need.

Year Founded

2015

AUM

$167.3M

Portfolio Companies

18

Investments

4BIO Capital investments
CompanyDateStageLead
SesenMar 2023Reverse MergerCo-investor
Entact BioDec 2022Series ACo-investor
March BiosciencesOct 2024Series ALead
NV TherapeuticsMar 2025SeedLead
Undecimal BioOct 2026SeedLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Dima Kuzmin

Managing Partner

Brian McVeigh

Venture Partner

Tay Salimullah

Venture Partner

Therese Liechtenstein

Partner

Natalie Johnston

Principal

Kieran Mudryy

Partner, General Counsel

Book a demo to see all key people

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is 4BIO Capital based?

4BIO Capital is headquartered in London, United Kingdom.

When was 4BIO Capital founded?

4BIO Capital was founded in 2015.

How many portfolio companies does 4BIO Capital have?

4BIO Capital has 18 portfolio companies in Caplight's dataset.

What are some companies in 4BIO Capital's portfolio?

Portfolio companies visible on Caplight include Sesen, Entact Bio, March Biosciences, NV Therapeutics, Undecimal Bio.

What was 4BIO Capital's most recent investment shown here?

4BIO Capital's most recent investment in this portfolio sample was in Undecimal Bio in 2026.

What sectors does 4BIO Capital focus on?

4BIO Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software.

What company stages does 4BIO Capital focus on?

4BIO Capital typically invests at the Early stage.

Firmographic Details

HeadquartersLondon
Year Founded2015
AUM$167.3M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?